<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7479EFF8-8EF7-479B-BB26-3D844EB92D8E"><gtr:id>7479EFF8-8EF7-479B-BB26-3D844EB92D8E</gtr:id><gtr:name>University of Goettingen</gtr:name><gtr:address><gtr:line1>Windausweg 2</gtr:line1><gtr:postCode>D-37073</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CE676888-B62B-4605-8718-8F05F5A0913C"><gtr:id>CE676888-B62B-4605-8718-8F05F5A0913C</gtr:id><gtr:name>Consorcio Ciber Para el Area Tematica De Salud Mental Celso Arango CIBERSAM</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7E0D8BA5-3E18-4785-911E-36BF394481E6"><gtr:id>7E0D8BA5-3E18-4785-911E-36BF394481E6</gtr:id><gtr:name>Region Hovedstadens Psykiatri</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476"><gtr:id>B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476</gtr:id><gtr:name>University Medical Centre Utrecht</gtr:name><gtr:address><gtr:line1>Unversity Medical Centre Utrecht</gtr:line1><gtr:line2>Rudolf Magnus Institute for Neuroscience</gtr:line2><gtr:line3>PO Box 85060</gtr:line3><gtr:postCode>NL-3508 AB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7DE845E5-F9D0-407F-9741-10E54FDC0FE4"><gtr:id>7DE845E5-F9D0-407F-9741-10E54FDC0FE4</gtr:id><gtr:name>University of Maastricht</gtr:name><gtr:address><gtr:line1>Department of Paediatrics</gtr:line1><gtr:line2>Universiteitssingel 50</gtr:line2><gtr:postCode>6200MD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E9C1E9A6-D4BE-49EB-8DBC-00F46BF2DE68"><gtr:id>E9C1E9A6-D4BE-49EB-8DBC-00F46BF2DE68</gtr:id><gtr:name>Hoffmann-La Roche</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A2D07311-AE35-4F0F-BE89-F2CAB63EE088"><gtr:id>A2D07311-AE35-4F0F-BE89-F2CAB63EE088</gtr:id><gtr:name>Cambridge Cognition Ltd</gtr:name><gtr:address><gtr:line1>Tunbridge Court</gtr:line1><gtr:line2>Tunbridge Lane</gtr:line2><gtr:postCode>CB25 9TU</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/276CCBAB-1433-4E39-BEA5-E8327D170815"><gtr:id>276CCBAB-1433-4E39-BEA5-E8327D170815</gtr:id><gtr:name>Servicio C?ntabro de Salud</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/38604300-D348-417A-994D-AC90FDF777D7"><gtr:id>38604300-D348-417A-994D-AC90FDF777D7</gtr:id><gtr:name>National University of Ireland Galway</gtr:name><gtr:address><gtr:line1>National University of Ireland Galway</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/42E115D6-74A7-41AB-8729-C3F169DB4ECC"><gtr:id>42E115D6-74A7-41AB-8729-C3F169DB4ECC</gtr:id><gtr:name>Ixico</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Psychological Medicine</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7479EFF8-8EF7-479B-BB26-3D844EB92D8E"><gtr:id>7479EFF8-8EF7-479B-BB26-3D844EB92D8E</gtr:id><gtr:name>University of Goettingen</gtr:name><gtr:address><gtr:line1>Windausweg 2</gtr:line1><gtr:postCode>D-37073</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CE676888-B62B-4605-8718-8F05F5A0913C"><gtr:id>CE676888-B62B-4605-8718-8F05F5A0913C</gtr:id><gtr:name>Consorcio Ciber Para el Area Tematica De Salud Mental Celso Arango CIBERSAM</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7E0D8BA5-3E18-4785-911E-36BF394481E6"><gtr:id>7E0D8BA5-3E18-4785-911E-36BF394481E6</gtr:id><gtr:name>Region Hovedstadens Psykiatri</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476"><gtr:id>B92C1E49-4D20-4A69-BDBE-BDEC1AE2A476</gtr:id><gtr:name>University Medical Centre Utrecht</gtr:name><gtr:address><gtr:line1>Unversity Medical Centre Utrecht</gtr:line1><gtr:line2>Rudolf Magnus Institute for Neuroscience</gtr:line2><gtr:line3>PO Box 85060</gtr:line3><gtr:postCode>NL-3508 AB</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7DE845E5-F9D0-407F-9741-10E54FDC0FE4"><gtr:id>7DE845E5-F9D0-407F-9741-10E54FDC0FE4</gtr:id><gtr:name>University of Maastricht</gtr:name><gtr:address><gtr:line1>Department of Paediatrics</gtr:line1><gtr:line2>Universiteitssingel 50</gtr:line2><gtr:postCode>6200MD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E9C1E9A6-D4BE-49EB-8DBC-00F46BF2DE68"><gtr:id>E9C1E9A6-D4BE-49EB-8DBC-00F46BF2DE68</gtr:id><gtr:name>Hoffmann-La Roche</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A2D07311-AE35-4F0F-BE89-F2CAB63EE088"><gtr:id>A2D07311-AE35-4F0F-BE89-F2CAB63EE088</gtr:id><gtr:name>Cambridge Cognition Ltd</gtr:name><gtr:address><gtr:line1>Tunbridge Court</gtr:line1><gtr:line2>Tunbridge Lane</gtr:line2><gtr:postCode>CB25 9TU</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/276CCBAB-1433-4E39-BEA5-E8327D170815"><gtr:id>276CCBAB-1433-4E39-BEA5-E8327D170815</gtr:id><gtr:name>Servicio C?ntabro de Salud</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F5914C2A-6AE8-4A26-ACA8-99C3D6D87514"><gtr:id>F5914C2A-6AE8-4A26-ACA8-99C3D6D87514</gtr:id><gtr:name>University of Melbourne</gtr:name><gtr:address><gtr:line1>University of Melbourne</gtr:line1><gtr:line2>Melbourne Research Office</gtr:line2><gtr:line3>Parkville</gtr:line3><gtr:line4>Melbourne</gtr:line4><gtr:line5>Victoria</gtr:line5><gtr:postCode>3010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/38604300-D348-417A-994D-AC90FDF777D7"><gtr:id>38604300-D348-417A-994D-AC90FDF777D7</gtr:id><gtr:name>National University of Ireland Galway</gtr:name><gtr:address><gtr:line1>National University of Ireland Galway</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/42E115D6-74A7-41AB-8729-C3F169DB4ECC"><gtr:id>42E115D6-74A7-41AB-8729-C3F169DB4ECC</gtr:id><gtr:name>Ixico</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0B7BA49E-A505-41DC-AB71-A59E5DEB972E"><gtr:id>0B7BA49E-A505-41DC-AB71-A59E5DEB972E</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Grasby</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2DFB367E-B573-4DFE-99B9-0E2DA8CB5821"><gtr:id>2DFB367E-B573-4DFE-99B9-0E2DA8CB5821</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F9769D85-756D-4141-B7AC-B661F01727EC"><gtr:id>F9769D85-756D-4141-B7AC-B661F01727EC</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Allen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F664E697-5681-4CA8-9324-0C97321CDB72"><gtr:id>F664E697-5681-4CA8-9324-0C97321CDB72</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:surname>Murray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/61FCED78-87E1-4671-88B2-84296826EB55"><gtr:id>61FCED78-87E1-4671-88B2-84296826EB55</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>McGuire</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/93DFBBCC-4BFF-4D72-A55A-C63D84DD645B"><gtr:id>93DFBBCC-4BFF-4D72-A55A-C63D84DD645B</gtr:id><gtr:firstName>Oliver</gtr:firstName><gtr:surname>Howes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700995"><gtr:id>5247C0E5-B3AA-4B55-A018-5A190BF4CEE6</gtr:id><gtr:title>Social adversity, dopamine, cognition and psychosis (response to the neurobiological basis of mental health highlight)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700995</gtr:grantReference><gtr:abstractText>Psychotic illnesses, such as schizophrenia, are common devastating conditions. Individuals with psychosis experience delusions, hallucinations and difficulties with thinking and planning. The cause of psychosis is not known. However, research shows that levels of the chemical messenger, dopamine, are increased in the brain. Other research indicates that patients have particular difficulty with planning and thinking, and this appears to be related to malfunction in the prefrontal part of the brain. Finally, the risk of developing psychosis is significantly increased in people who have been exposed to long-term social stressors. Until now, these factors have mainly been studied separately. A key aim of this project is to put information on dopamine, prefrontal brain function and social stressors in psychosis together and clarify the relationship between them. We plan to do this by measuring dopamine function and prefrontal activity using brain scanning, and measuring social stressors with specific research interviews. We will do this in people who are very vulnerable to psychosis, and have a high risk of developing the illness in the near future. We will assess these individuals at the start of the study and again after 12 months, then follow them up to find out who subsequently develops a psychotic illness. This will allow us to find which factors indicate that someone is at high risk of psychosis, and how changes in these factors over time are linked to the development of psychosis. This will help with the early identification of individuals who are vulnerable to psychosis and the development of new treatments designed to prevent the later onset of psychosis in people who are at high risk.</gtr:abstractText><gtr:technicalSummary>The pathophysiological mechanisms leading to psychosis are poorly understood. Elevated striatal dopamine synthesis and release, impaired performance on tasks involving prefrontal cortex, and abnormal prefrontal activation during these tasks have been consistently reported in people with psychotic disroders, including medication na?ve patients at the onset of illness. The incidence of psychosis has been strongly associated with environmental factors such as belonging to an ethnic minority or immigrant group and living in an urban area. These factors are associated with social adversity and it has been suggested that their cumulative effect is a state of social defeat. Central dopamine activity and prefrontal cortical function are normally inter-related, and animal studies indicate that social stress and defeat can elevate both striatal and prefrontal dopamine levels. However, to date, dopaminergic function, cognitive processing and social factors in psychosis have largely been investigated separately. The aim of the present proposal is to integrate data from these different domains by studying each of them in the same individuals using PET, fMRI and social measures. These will be examined in a longitudinal study of people with an At Risk Mental State (ARMS). Around a third of this group are likely to subsequently develop psychosis, a third remain stable and a third will improve. Participants will be assessed at baseline and after 12 months. Cross-sectional comparison of the ARMS group with controls will reveal the extent to which social factors, dopaminergic activity, and prefrontal function are abnormal in people at high risk of psychosis. Further, the prospective study of this group over its divergent clinical course, with repetition of the baseline assessments, will indicate the relationship between the longitudinal trajectory of these abnormalities and clinical outcome. Our hypothesis is that these abnormalities progress in the subgroup of subjects that goes on to develop the illness, but not in these at risk subjects who do not become psychotic. This work will help to identify factors that are critical to the onset of psychosis, and may therefore inform the development of interventions designed to prevent the the onset of psychosis in people who are vulnerable to the disorder.</gtr:technicalSummary><gtr:fund><gtr:end>2013-02-17</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-08-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>739743</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Medical Center Utrecht (UMC)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>AE7069EE-CD58-4DEA-97CB-29630815EDFB</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ixico</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PSYSCAN</gtr:description><gtr:id>853ECC8C-D378-42D2-B327-78FD2EDA71B0</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK ultra high risk in psychosis network</gtr:description><gtr:id>7243560C-6C16-46EC-B02E-2FCDA98BFDA4</gtr:id><gtr:impact>Wellcome trust grant 'Neurobiological factors underlying the onset of psychosis'</gtr:impact><gtr:partnerContribution>Recruiment and assessment of study participants</gtr:partnerContribution><gtr:piContribution>In continuation of the success of the research funded by this grant we have received funding from the Wellcome trust to further this work in collaboration with the above listed institutions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Psychiatry</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>5DDB77EB-2706-45EB-A7C7-A5CEDD5896C9</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cambridge Cognition Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PSYSCAN</gtr:description><gtr:id>610E4600-446C-40A4-9A5D-376B0C0D9AD7</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maastricht (UM)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Psychiatry and Neuropsychology</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>EBB48D50-44AB-4E59-A47B-3054D80186A4</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Psychiatry</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>B37C7D22-34F8-4621-B73B-FD583DAEBBAC</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hoffmann-La Roche</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Psychiatry</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>26BF0612-30F9-426E-9F29-4EDCB3D8F8AB</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK ultra high risk in psychosis network</gtr:description><gtr:id>1EC4E529-3425-486F-AE01-F51F52C86BE6</gtr:id><gtr:impact>Wellcome trust grant 'Neurobiological factors underlying the onset of psychosis'</gtr:impact><gtr:partnerContribution>Recruiment and assessment of study participants</gtr:partnerContribution><gtr:piContribution>In continuation of the success of the research funded by this grant we have received funding from the Wellcome trust to further this work in collaboration with the above listed institutions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre</gtr:department><gtr:description>Link with MRC PET facility</gtr:description><gtr:id>7267A8A6-F83E-4560-A951-D6177683ECA7</gtr:id><gtr:impact>Multimodal imaging - integration of fMRI and PET data
Publications include those mentioned in the previous publication section</gtr:impact><gtr:partnerContribution>Scanning of research participants with 18F-DOPA radiotracer to quantify presynaptic dopamine transmission in the Ultra High Risk State.</gtr:partnerContribution><gtr:piContribution>Recruitment and assessment of research participants in addition to data-analysis of 18F-DOPA PET scans</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska University Hospital</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Swedish equivalent</gtr:description><gtr:id>55FE4926-BF7C-4497-9192-390ED94E1644</gtr:id><gtr:impact>None yet</gtr:impact><gtr:partnerContribution>data</gtr:partnerContribution><gtr:piContribution>Data from our study has been compared with theirs</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Consorcio Ciber Para el Area Tematica De Salud Mental Celso Arango CIBERSAM</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Psychiatry</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>1B70D0D3-54BD-45F5-ACFB-6F948F84C13E</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biological Sciences Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Psychology</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>FC11AE84-A48F-431E-BD12-4A874F9CE5EE</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Melbourne</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>E19DFBFD-B348-411F-B254-4C9FC48860F2</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Goettingen Medical School</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Psychiatry and Psychotherapy</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>D7CB5A44-F3E7-401C-84F7-FF1FF30446C7</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK ultra high risk in psychosis network</gtr:description><gtr:id>9E8D3242-8EE8-4731-A810-0F7B5B9DEA11</gtr:id><gtr:impact>Wellcome trust grant 'Neurobiological factors underlying the onset of psychosis'</gtr:impact><gtr:partnerContribution>Recruiment and assessment of study participants</gtr:partnerContribution><gtr:piContribution>In continuation of the success of the research funded by this grant we have received funding from the Wellcome trust to further this work in collaboration with the above listed institutions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Region Hovedstadens Psykiatri</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>PSYSCAN</gtr:description><gtr:id>EED8BD4C-887D-4CDE-B6A1-CB674A203384</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Servicio C?ntabro de Salud</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Clinical and Social Psychiatry Research Unit</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>E60D55F6-BE87-45F1-9507-F2CD7B109292</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National University of Ireland</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>PSYSCAN</gtr:description><gtr:id>2DCB9701-9753-4609-A458-7EEA91CD0FF7</gtr:id><gtr:impact>The PSYSCAN project was funded by the EC as part of Framework 7.
http://ec.europa.eu/research/health/medical-research/brain-research/projects/psyscan_en.html</gtr:impact><gtr:partnerContribution>As above</gtr:partnerContribution><gtr:piContribution>We are an integral part of this research consortium which had led to a successful bud for EU-FP7 funding</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5998346</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU-FP7</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:fundingRef>603196</gtr:fundingRef><gtr:id>D0D046C2-010F-4E9C-9302-F044511ED922</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1054000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>AC349DC5-34BF-4FF5-982F-49FEBAC902E8</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>427000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Commission FP7</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>EC14E907-7770-47D6-B5E0-B21184A2E592</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/487AC92D-C7CA-4308-A3FE-E97F7E428AC0"><gtr:id>487AC92D-C7CA-4308-A3FE-E97F7E428AC0</gtr:id><gtr:title>Perceived ethnic discrimination and persecutory paranoia in individuals at ultra-high risk for psychosis.</gtr:title><gtr:parentPublicationTitle>Psychiatry research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af50a386b662467f252f056120383a71"><gtr:id>af50a386b662467f252f056120383a71</gtr:id><gtr:otherNames>Shaikh M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0165-1781</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7DFA9B1C-C260-417C-BADD-937E7ED949AE"><gtr:id>7DFA9B1C-C260-417C-BADD-937E7ED949AE</gtr:id><gtr:title>Elevated striatal dopamine function linked to prodromal signs of schizophrenia.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0691a45ce814dfc6ab4c3e6dd94e781"><gtr:id>a0691a45ce814dfc6ab4c3e6dd94e781</gtr:id><gtr:otherNames>Howes OD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4844575C-180F-4919-A44A-E3991FB33005"><gtr:id>4844575C-180F-4919-A44A-E3991FB33005</gtr:id><gtr:title>Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0691a45ce814dfc6ab4c3e6dd94e781"><gtr:id>a0691a45ce814dfc6ab4c3e6dd94e781</gtr:id><gtr:otherNames>Howes OD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6A7BCA9-BA29-469A-BB94-22D36604F855"><gtr:id>F6A7BCA9-BA29-469A-BB94-22D36604F855</gtr:id><gtr:title>Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49b1a2224b337a1dda5d402fdfa5fb51"><gtr:id>49b1a2224b337a1dda5d402fdfa5fb51</gtr:id><gtr:otherNames>Stone JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/566F7749-8B2D-4710-A974-21C087881A7E"><gtr:id>566F7749-8B2D-4710-A974-21C087881A7E</gtr:id><gtr:title>Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0980c02bfccd40546661ada4b20eaaa1"><gtr:id>0980c02bfccd40546661ada4b20eaaa1</gtr:id><gtr:otherNames>Roiser JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA9E7382-95B1-4B13-83B9-AB43D2BA7561"><gtr:id>BA9E7382-95B1-4B13-83B9-AB43D2BA7561</gtr:id><gtr:title>Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d291d20ff6b7d57155002e6583fb3ce2"><gtr:id>d291d20ff6b7d57155002e6583fb3ce2</gtr:id><gtr:otherNames>Fusar-Poli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22C1A0CE-ADD4-4060-98CD-727070FBF0EE"><gtr:id>22C1A0CE-ADD4-4060-98CD-727070FBF0EE</gtr:id><gtr:title>Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d291d20ff6b7d57155002e6583fb3ce2"><gtr:id>d291d20ff6b7d57155002e6583fb3ce2</gtr:id><gtr:otherNames>Fusar-Poli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51F09DFB-C062-461D-8322-828911B00945"><gtr:id>51F09DFB-C062-461D-8322-828911B00945</gtr:id><gtr:title>The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a79e5d2d5d5dfbe5a7d92af4cf5c830a"><gtr:id>a79e5d2d5d5dfbe5a7d92af4cf5c830a</gtr:id><gtr:otherNames>Egerton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CEF0D878-4B2B-4242-B55A-A7A7EBA80ADA"><gtr:id>CEF0D878-4B2B-4242-B55A-A7A7EBA80ADA</gtr:id><gtr:title>Functionally defined regions may aid interpretation of striatal dopamine elevation in schizophrenia.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a79e5d2d5d5dfbe5a7d92af4cf5c830a"><gtr:id>a79e5d2d5d5dfbe5a7d92af4cf5c830a</gtr:id><gtr:otherNames>Egerton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2D9AFF12-010C-48E8-9453-4A0D3914099C"><gtr:id>2D9AFF12-010C-48E8-9453-4A0D3914099C</gtr:id><gtr:title>Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a79e5d2d5d5dfbe5a7d92af4cf5c830a"><gtr:id>a79e5d2d5d5dfbe5a7d92af4cf5c830a</gtr:id><gtr:otherNames>Egerton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9535C598-4C62-4852-9250-367E7899D055"><gtr:id>9535C598-4C62-4852-9250-367E7899D055</gtr:id><gtr:title>Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce4ab107178e3e91d84a742dbaab1870"><gtr:id>ce4ab107178e3e91d84a742dbaab1870</gtr:id><gtr:otherNames>Allen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82E62BF6-C6EC-45A7-83FA-BD804C1E3E07"><gtr:id>82E62BF6-C6EC-45A7-83FA-BD804C1E3E07</gtr:id><gtr:title>Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b3dfa96a9ff12ea5516b963792374da2"><gtr:id>b3dfa96a9ff12ea5516b963792374da2</gtr:id><gtr:otherNames>Howes O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5762B1C0-B8F3-4025-90C5-154C755FA6C0"><gtr:id>5762B1C0-B8F3-4025-90C5-154C755FA6C0</gtr:id><gtr:title>Adversity in childhood linked to elevated striatal dopamine function in adulthood.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a79e5d2d5d5dfbe5a7d92af4cf5c830a"><gtr:id>a79e5d2d5d5dfbe5a7d92af4cf5c830a</gtr:id><gtr:otherNames>Egerton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BB7F8EE8-6105-437F-83D5-A81A0B5D154B"><gtr:id>BB7F8EE8-6105-437F-83D5-A81A0B5D154B</gtr:id><gtr:title>Neurobiological basis of motivational deficits in psychopathology.</gtr:title><gtr:parentPublicationTitle>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d1b6c947b5355c1ed4b120dd018f8ffd"><gtr:id>d1b6c947b5355c1ed4b120dd018f8ffd</gtr:id><gtr:otherNames>Salamone JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0924-977X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F43650D-BD08-454D-87E2-20EAFB493CCD"><gtr:id>0F43650D-BD08-454D-87E2-20EAFB493CCD</gtr:id><gtr:title>Glutamate and psychosis risk.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a79e5d2d5d5dfbe5a7d92af4cf5c830a"><gtr:id>a79e5d2d5d5dfbe5a7d92af4cf5c830a</gtr:id><gtr:otherNames>Egerton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47227447-521C-4253-B8AF-3E371D179923"><gtr:id>47227447-521C-4253-B8AF-3E371D179923</gtr:id><gtr:title>Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d291d20ff6b7d57155002e6583fb3ce2"><gtr:id>d291d20ff6b7d57155002e6583fb3ce2</gtr:id><gtr:otherNames>Fusar-Poli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3EAF586-FB5E-4499-934C-5995F873B1DD"><gtr:id>B3EAF586-FB5E-4499-934C-5995F873B1DD</gtr:id><gtr:title>The nature of dopamine dysfunction in schizophrenia and what this means for treatment.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0691a45ce814dfc6ab4c3e6dd94e781"><gtr:id>a0691a45ce814dfc6ab4c3e6dd94e781</gtr:id><gtr:otherNames>Howes OD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32833B58-FEF2-4C90-9215-8D23BA447BEB"><gtr:id>32833B58-FEF2-4C90-9215-8D23BA447BEB</gtr:id><gtr:title>Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce4ab107178e3e91d84a742dbaab1870"><gtr:id>ce4ab107178e3e91d84a742dbaab1870</gtr:id><gtr:otherNames>Allen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BECAB2B6-0114-4304-93B7-A63BCCC26D53"><gtr:id>BECAB2B6-0114-4304-93B7-A63BCCC26D53</gtr:id><gtr:title>Is clinical intervention in the ultra high risk phase effective?</gtr:title><gtr:parentPublicationTitle>Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/31467d4a8a2dee0bc64957171260598f"><gtr:id>31467d4a8a2dee0bc64957171260598f</gtr:id><gtr:otherNames>McGuire P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1516-4446</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CA622DDC-5124-4CCF-B77E-463D04510953"><gtr:id>CA622DDC-5124-4CCF-B77E-463D04510953</gtr:id><gtr:title>From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0691a45ce814dfc6ab4c3e6dd94e781"><gtr:id>a0691a45ce814dfc6ab4c3e6dd94e781</gtr:id><gtr:otherNames>Howes OD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/479CE1BB-C75C-4F4C-A6DE-A9C4288D6E7D"><gtr:id>479CE1BB-C75C-4F4C-A6DE-A9C4288D6E7D</gtr:id><gtr:title>Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce4ab107178e3e91d84a742dbaab1870"><gtr:id>ce4ab107178e3e91d84a742dbaab1870</gtr:id><gtr:otherNames>Allen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C6717182-25CF-423F-897C-C64888BA34D9"><gtr:id>C6717182-25CF-423F-897C-C64888BA34D9</gtr:id><gtr:title>Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce4ab107178e3e91d84a742dbaab1870"><gtr:id>ce4ab107178e3e91d84a742dbaab1870</gtr:id><gtr:otherNames>Allen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6D81707-FEB4-4C4C-B96F-3DDB0D5307C7"><gtr:id>F6D81707-FEB4-4C4C-B96F-3DDB0D5307C7</gtr:id><gtr:title>Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a79e5d2d5d5dfbe5a7d92af4cf5c830a"><gtr:id>a79e5d2d5d5dfbe5a7d92af4cf5c830a</gtr:id><gtr:otherNames>Egerton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EE767B8-A0D7-47F8-B029-8312B022E467"><gtr:id>6EE767B8-A0D7-47F8-B029-8312B022E467</gtr:id><gtr:title>Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49b1a2224b337a1dda5d402fdfa5fb51"><gtr:id>49b1a2224b337a1dda5d402fdfa5fb51</gtr:id><gtr:otherNames>Stone JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700995</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>